Celonic Group

Celonic Group is a Biologics Development and Manufacturing CDMO providing services to bring life-saving and improving drugs effectively to the market. Established in 1982, Celonic is a "Pure Play" Biologics Contract Development Manufacturing Organization (CDMO) with a mission to aid its primarily small to large Biotech Companies clientele. The company operates from its headquarters in Basel, Switzerland, and clinical and commercial GMP manufacturing facilities in Heidelberg, Germany. With more than 500 highly qualified employees, Celonic emphasizes innovation and employs "next generation" bioprocessing technologies. The company's focus on process intensification and full-perfusion showcases its commitment to advancing the biotechnology industry. Celonic's expansion plans include the recruitment of committed and qualified employees to further its impact on the sector. Overall, Celonic's position as a key player in the industry, coupled with its commitment to innovation, makes it an attractive prospect for potential investors looking to capitalize on the evolving biotechnology landscape.